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Abstract
Analysis of protein phosphorylation in highly purified rat brain mitochondria revealed the presence of several alkali-
stable phosphoproteins whose phosphorylation markedly increases upon treatment with peroxovanadate and Mn2þ, a
property indicating tyrosine phosphorylation. These include three prominent bands, with apparent sizes of 50, 60, and 75
kDa, which are detectable by anti-phosphotyrosine. Tyrosine phosphorylation disappears when mitochondria are treated
with PP2, an inhibitor of the Src kinase family, suggesting the presence of members of this family in rat brain
mitochondria. Immunoblotting and immunoprecipitation assays of mitochondrial lysates confirmed the presence of Fyn,
Src and Lyn kinases, as well as Csk, a protein kinase which negatively controls the activity of the Src kinase family. Results
show that tyrosine-phosphorylated proteins are membrane-bound and that they are located on the inner surface of the
outer membrane and/or the external surface of the inner membrane. Instead, Src tyrosine kinases are mainly located in the
intermembrane space ^ in particular, as revealed by immunogold experiments for Lyn kinase, in the cristal lumen. Rat
brain mitochondria were also found to possess a marked level of tyrosine phosphatase activity, strongly inhibited by
peroxovanadate. 6 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Protein phosphorylation is implicated in a large
number of cell processes, particularly signal trans-
duction pathways and enzymatic regulation [1]. Sig-
nal transduction involving protein phosphorylation is
generally triggered at cell surface receptors with ty-
rosine kinase activity and, as a consequence, the plas-
ma membrane has been considered the main subcel-
lular site of such activities [2]. However, tyrosine
phosphorylation has also been detected in the nu-
clear envelope and endoplasmic reticulum mem-
branes [3]. Besides receptor tyrosine kinases, a group
of intracellular type, exempli¢ed by the Src family
(Src, Fyn, Lyn, Fgr, etc.), may serve as control
switches in a variety of signal transduction pathways
governing essential cell processes [4]. Receptor tyro-
sine kinases and receptors lacking intrinsic tyrosine
kinase activity interact with members of the Src fam-
ily [5^9]. Tyrosine phosphorylation by these kinases
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is a reversible process which depends on the activity
of tyrosine phosphatases. Depending on the cellular
context, tyrosine phosphatases can either antagonize
the action of tyrosine kinases or cooperate with
them. The activation of the Src family kinases by
tyrosine phosphatases is an example of positive co-
operation between these systems [8]. Inhibition of
cellular tyrosine phosphatase activities may result in
increased levels of tyrosine-phosphorylated proteins,
implying the existence of a dynamic relationship be-
tween tyrosine phosphorylation and dephosphoryla-
tion pathways. Conditions of oxidative stress may
modify the activity of major signalling enzymes, in-
cluding tyrosine kinases and phosphatases [10].
Mitochondria and individual mitochondrial pro-
teins are known to participate in processes involving
signal transduction pathways, including programmed
cell death [11], neoplastic proliferation and oxidative
stress [11^13]. Protein phosphorylation has been rec-
ognized to cover very important functions in signal
transduction; however, whereas Ser/Thr phosphory-
lation in mitochondria has been studied in depth [14^
16], there are few studies on the presence of a mito-
chondrial tyrosine kinase [17^19]. In particular, in
brain mitochondria no report deals with this subject.
The main aim of the present study was to identify
the occurrence of tyrosine kinase activity and of cor-
responding substrates associated with brain mito-
chondria, to gain information on the family(ies) of
tyrosine kinases mainly involved and to reveal tyro-
sine phosphatase activity which modulates tyrosine
phosphorylation. Another aim was to gain informa-
tion on the location of these enzymes and their sub-
strates in mitochondrial subcompartments.
2. Materials and methods
2.1. Materials
[Q-32P]ATP was purchased from Amersham. 4-
Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-
d]pyrimidine (PP2), genistein, piceatannol and radi-
cicol were obtained from Calbiochem and protease
inhibitor cocktail from Boehringer. Peroxovanadate
was prepared by mixing hydrogen peroxide (3 mmol/
l) and sodium orthovanadate (2 mmol/l).
Anti-phosphotyrosine monoclonal antibodies were
purchased from ICN Biotechnology, anti-cyto-
chrome c monoclonal antibodies from PharMingen,
anti-L-actin polyclonal antibodies from Sigma, anti-
PCNA, anti-PDGF receptor, anti-Bip, anti-HSP-60,
anti-Lyn, anti-Fyn, anti-Src and anti-Csk polyclonal
antibodies from Santa Cruz Biotechnology, anti-cav-
eolin polyclonal antibodies from Lab. Transduction.
Other reagents were purchased from Sigma.
2.2. Preparation of mitochondria
Rat brain mitochondria (RBM) were puri¢ed by
the Ficoll gradient method, according to Nicholls,
with some modi¢cations. Brie£y, rat brain (cerebral
cortex) was homogenized in isolation medium (320
mM sucrose, 5 mM HEPES, 0.5 mM EDTA, pH
7.4; 0.3% BSA was added during homogenization
and the ¢rst step of puri¢cation) and subjected to
centrifugation (900Ug) for 5 min. The supernatant
was then centrifuged at 17 000Ug for 10 min, to
precipitate crude mitochondrial pellets. These were
resuspended in isolation medium plus 1 mM ATP
and layered on top of a discontinuous gradient, com-
posed of 2 ml of isolation medium containing 16%
(w/v) Ficoll, 2 ml of isolation medium containing
14% (w/v) Ficoll, 3 ml of isolation medium contain-
ing 12% (w/v) Ficoll, and 3 ml of isolation medium
containing 7% (w/v) Ficoll. The gradient was centri-
fuged for 30 min at 75 000Ug. Mitochondrial pellets
were suspended in isolation medium and centrifuged
for 10 min at 17 000Ug. Again the pellets were sus-
pended in isolation medium without EDTA. Protein
content was measured by the biuret method with
bovine serum albumin as a standard [22]. To sepa-
rate mitochondrial membranes from the soluble frac-
tion, 10 mg/ml of mitochondria were exposed to ul-
trasonic energy (MSE Sonicator) and subjected to
eight freeze/thaw cycles. Mitochondrial suspensions
were then centrifuged at 100 000Ug to obtain mem-
brane pellets and supernatant fractions.
2.3. Marker enzymes
NADPH-cytochrome c reductase activity was as-
sayed as described by Sottocasa et al. [23]. Glucose-
6-phosphatase activity was measured according to
Swanson [24]. The inorganic phosphate liberated
during incubation was determined as described by
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Baginski et al. [25]. Monoamine oxidase activity was
assayed as described by Tabor et al. [26]. Adenylate
kinase, cytochrome c oxidase, and malate dehydro-
genase activities were determined according to Dor-
bani et al. [27].
2.4. Western blot analysis to assess the mitochondrial
purity
Brain homogenate in mitochondrial isolation me-
dium [21] and mitochondrial suspension were lysed
with 20 mM Tris^HCl, pH 7.5, 10% glycerol, 1%
Nonidet P-40, 1 mM EDTA, 50 mM NaCl. Both
in the amount of 30 Wg protein were subjected to
SDS^PAGE and analysed by Western blotting.
2.5. Determination of integrity of mitochondria
Membrane potential (v8) was measured by mon-
itoring the distribution of the lipophilic cation, tet-
raphenylphosphonium, across the mitochondrial
membrane, using a selective electrode prepared in
our laboratory according to published procedures
[28]. Membrane potential measured with this elec-
trode was corrected as proposed by Jensen [29].
Care was taken to keep the tetraphenylphospho-
nium concentration below inhibitory levels, as pre-
viously indicated [30]. The mitochondrial matrix
volume was calculated from the distribution of
[14C]sucrose and 3H2O, according to Palmieri and
Klingenberg [31].
A centrifugal ¢ltration method was used to mea-
sure mitochondrial uptake of [14C]ADP [30]. Swelling
was estimated by changes in absorbance at 540 nm
on a Perkin-Elmer Lambda 5 spectrophotometer
equipped with thermostatic control.
2.6. Digitonin treatment
Submitochondrial fractions were obtained by the
digitonin method (0.2 or 0.6 mg digitonin/mg of mi-
tochondrial protein), as described by Dorbani et al.
[27].
2.7. Phosphorylation assays
Endogenous phosphorylation of mitochondria was
measured by incubating 50 Wg of mitochondria at
30‡C for 10 min in 30 Wl of reaction medium con-
taining 200 mM sucrose, 10 mM HEPES (pH 7.4),
5 mM MnCl2, and 20 WM [Q-32P]ATP (3U106 cpm/
nmol). Enolase phosphorylation assays were per-
formed as described previously [32].
Reactions were stopped by the addition of 2%
SDS and 1% 2-mercaptoethanol (¢nal concentra-
tions) followed by 5 min treatment at 100‡C, as de-
scribed [33]. Solubilized mitochondria were analysed
by SDS^PAGE, essentially according to Laemmli
[34].
After electrophoresis, gels were stained with Coo-
massie brilliant blue according to Laemmli [34], sub-
mitted to 2 M NaOH treatment at 55‡C as described
[33] and again ¢xed. Dried gels were then autoradio-
graphed at 380‡C with intensifying screens. Other-
wise, after electrophoresis, gels were transferred to
nitrocellulose membranes and immunostained with
anti-phosphotyrosine antibody. A blocked anti-phos-
photyrosine antibody has also been prepared that
was incubated overnight with an excess of phospho-
tyrosine.
Quantitation of band intensity in Western analysis
was accomplished using Image Station 440, Kodak.
2.8. Phosphoamino acid analysis
To determine phosphoamino acid levels in mito-
chondria, the phosphorylation reaction carried out as
described above was stopped by adding an appropri-
ate volume of HCl (¢nal concentration 6 N), and
acid hydrolysed at 110‡C for 2 h in vacuum-sealed
tubes. The HCl was removed by evaporation and the
residue was dissolved in a marker mixture containing
phosphoserine, phosphothreonine and phosphotyro-
sine (1 mg/ml each) and analysed by bidirectional
paper electrophoresis [33] as follows. 50 Wl aliquots
of hydrolysate were spotted on Whatman 3 MM
paper (100 WM) paper and subjected to electropho-
resis in the ¢rst direction at pH 1.9 (acetic acid/for-
mic acid/H2O, 150:25:825) for 2 h at 2.4 kV and in
the second direction at pH 3.5 (acetic acid/pyridine/
H2O, 50:5:945) for 1 h at 2.4 kV. Markers were
detected by staining with ninhydrin, and 32P-labelled
phosphoamino acids were detected by autoradiogra-
phy.
BBAMCR 14849 3-5-02
M. Salvi et al. / Biochimica et Biophysica Acta 1589 (2002) 181^195 183
2.9. Assay for 32P-Tyr phosphatase activity using
poly(Glu-32P-Tyr)4:1 as substrate
The phosphatase assay was carried out by incubat-
ing RBM (50 Wg) at 30‡C for 15 min in a medium (30
Wl) containing 15 pmol 32P-poly(Glu-Tyr) (corre-
sponding to 0.024 WCi/Wg) previously phosphorylated
as described [33]. The reaction was stopped by the
addition of 2% SDS and 1% 2-mercaptoethanol (¢nal
concentrations) followed by 5 min treatment at
100‡C as described [33].
2.10. Anti-Lyn, anti-Fyn, anti-Src and anti-Csk
immunoprecipitation (IP)
RBM were extracted for 1 h at 4‡C with 20 mM
Tris^HCl, pH 7.5, 10% glycerol, 1% Nonidet P-40,
1 mM EDTA, 50 mM NaCl and a protease inhibitor
cocktail. After centrifugation, supernatants were pre-
cleared by incubation with protein A-Sepharose for
45 min at 4‡C. Samples (2 mg mitochondrial protein)
were then incubated overnight at 4‡C with the ap-
propriate antibody bound to protein A-Sepharose.
Immune complexes were washed three times by cen-
trifugation and resuspended in 50 mM Tris^HCl, pH
7.5, containing a protease inhibitor cocktail.
2.11. Immune complex kinase assays
Tyrosine kinase assays of immune complexes, ob-
tained as described above, were performed in basal
medium (see Section 2.7) containing poly(Glu-
Tyr)4:1, which served as exogenous substrate. After
incubation for 10 min at 30‡C, samples were ana-
lysed by SDS^PAGE followed by autoradiography.
2.12. Immunogold labelling
RBM were ¢xed for 2 h in 4% paraformaldehyde
and 0.25% glutaraldehyde in 0.1 M phosphate bu¡er
(pH 7.2), post-¢xed for 1 h in 1% osmium tetroxide
in the same bu¡er, dehydrated in ethanol, and em-
bedded in London resin white. Ultrathin sections
picked up on gold grids were deosmicated with so-
dium metaperiodate, washed with 0.01 M PBS (pH
7.2), incubated for 20 min on 1% BSA in PBS, and
treated with rabbit primary polyclonal antibody
against tyrosine kinase Lyn. After washing with
PBS, sections were incubated with colloidal gold
(15 nm) conjugated with goat anti-rabbit IgG. Sec-
tions were then stained with uranyl acetate followed
by lead citrate and examined under the electron
microscope. A control experiment was performed
by eliminating the incubation of sections with the
primary antibody.
3. Results
Some cellular signal transduction events involving
mitochondria are associated with phosphorylation/
dephosphorylation processes, involving tyrosine resi-
dues in particular [7^10]. In order to verify whether
this post-translational modi¢cation takes place in the
mitochondrion, our main concern was to obtain mi-
tochondrial preparations free of contaminating mem-
branes, as tyrosine kinase is particularly active in the
plasma membrane and microsomes. The high purity
of the RBM obtained using the procedure applied
here is exempli¢ed in previous papers demonstrating
the negligible degree of activity of acetylcholinester-
ase [20] and lactate dehydrogenase [20,21] in such
preparations ^ an indication that the mitochondria
are free of plasma membrane and cytosol contami-
nation. Furthermore, electron microscopy demon-
strated the complete absence of contaminating mem-
brane fragments in the preparations [21]. In order to
verify that our own preparations were free of micro-
somes, a subcellular fraction with high tyrosine ki-
nase activity frequently present in isolated mitochon-
Table 1
Activity of NADPH-cytochrome c reductase and glucose-6-phosphatase in rat brain mitochondria and microsomes
Enzyme Microsomes (nmol/min/mg protein) Mitochondria (nmol/min/mg protein)
NADPH-cytochrome c reductase 10.02R 0.6 0.02R 0.003
Glucose-6-phosphatase 8.1R 0.4 0.02R 0.002
Activity expressed as nmol/mg protein.
Values are the means RS.D. from three independent experiments.
BBAMCR 14849 3-5-02
M. Salvi et al. / Biochimica et Biophysica Acta 1589 (2002) 181^195184
dria, we assayed for two microsomal marker en-
zymes, i.e. NADPH-cytochrome c reductase and glu-
cose-6-phosphatase, and found them to be nearly
undetectable (Table 1). Besides the above reported
enzymatic activity determinations and ultrastructural
observations, in order to have a complete evidence of
the purity of mitochondrial preparations, were also
performed Western blot analyses with other extrami-
tochondrial markers. These markers are: L-actin (cy-
toplasm), PCNA (nucleus), PDGFR (cell mem-
brane), and Bip (endoplasmic reticulum). We also
tested for caveolin, a protein particularly found in
caveolae, specialized regions of the plasma mem-
brane. The results reported in Fig. 1 show the West-
ern blot analyses performed in RBM suspension
(lane A) and in a brain homogenate (lane B). As
observable in the ¢gure, the immunoreactions are
completely negative for all the extramitochondrial
markers in the RBM preparations (lane A). Positive
reactions, instead, are observed for comparison, for
all markers, in the homogenate (lane B). The positive
reaction in both lanes refers to cytochrome c used as
mitochondrial marker.
Fig. 2 shows the patterns of phosphorylated mito-
chondrial proteins retained after NaOH treatment.
Patterns change according to phosphorylation condi-
tions. In the absence of peroxovanadate, only two
proteins, of 50 and 60 kDa, with a very low phos-
phorylation level, are observable (lanes a, b). The
addition of 5 WM oligomycin, an inhibitor of F1F0-
ATPase, increases their endogenous phosphoryla-
tion. The addition of 2 mM peroxovanadate to the
incubation medium stimulates the phosphorylation
of several proteins (lane c), including that of three
proteins of 50, 60 and 75 kDa, the levels of which are
further increased by treatment with oligomycin (lane
d). The e¡ect of oligomycin is very probably due to
the increased supply of non-hydrolysed ATP avail-
able in the presence of this inhibitor. A protein load-
ing standard of HSP 60 by Western blot is included
in this ¢gure for quantitative purpose.
Phosphorylation targets were identi¢ed by phos-
phoamino acid analysis of mitochondria, 32P-labelled
in a reaction mixture containing oligomycin in the
absence or presence of peroxovanadate (Fig. 3). In
its absence, phosphorylation mainly involves Ser and
to a lesser extent Thr residues, whereas tyrosine
phosphorylation is almost totally absent (Fig. 3A).
The addition of peroxovanadate markedly increases
the presence of 32P-Tyr, to a level comparable with
the phosphorylation of Thr residues (Fig. 3B).
To ascertain whether tyrosine phosphorylation
speci¢cally involves the proteins of 50, 60 and 75
kDa, Western blot analysis was performed using a
monoclonal anti-phosphotyrosine antibody, and the
presence of P-Tyr in each of the three proteins was
con¢rmed (Fig. 4A, lanes a, b). The other two per-
Fig. 1. Western blot analysis of mitochondrial and brain homo-
genate lysates, with anti-cytochrome (Cyt) c, anti-L-actin, anti-
PCNA, anti-PDGF receptor (PDGFR), anti-Bip and anti-cav-
eolin. Mitochondrial lysates (30 Wg) were subjected to immuno-
blot analysis with anti-Cyt c, anti-L-actin, anti-PCNA, anti-Bip,
anti-PDGFR and anti-caveolin (lane A). Brain homogenate ly-
sates (30 Wg) were subjected to immunoblot analysis with anti-
Cyt c, anti-L-actin, anti-PCNA, anti-PDGF receptor and anti-
caveolin (lane B).
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oxovanadate-insensitive bands were clearly non-spe-
ci¢c, as shown by a previously blocked anti-phos-
photyrosine antibody (Fig. 4A, lanes c, d).
As peroxovanadate is a well-known inhibitor of
tyrosine phosphatases [35], to check whether the ob-
served increase in phosphorylation was ascribable to
its action, the occurrence of tyrosine phosphatase
activity was veri¢ed in RBM using 32P-labelled
poly(Glu-Tyr)4:1 as a substrate, as described in Sec-
tion 2 (Fig. 4B). A V75% reduction in the phos-
phorylation of 32P-poly(Glu-Tyr)4:1 was observed
in the presence of 50 Wg RBM; with peroxovanadate
this activity was almost completely inhibited.
In order to identify the protein-tyrosine kinases
(PTKs) responsible for phosphorylation, we tested
the capability of a series of tyrosine kinase inhibitors
of di¡ering speci¢cities to inhibit phosphorylation in
the 50, 60 and 75 kDa proteins, detected after treat-
ment with peroxovanadate. Fig. 5 shows their inhib-
itory e¡ects on tyrosine phosphorylation of the 75
kDa protein; similar results were obtained with 50
and 60 kDa protein (data not shown).
Observations made using these inhibitors allowed
us to make some important considerations. First,
phosphorylation of 50, 60 and 75 kDa bands is al-
most completely prevented by 1 WM PP2, a molecule
which exerts a strong inhibitory e¡ect principally on
tyrosine kinase of the Src family [36], indicating that
these proteins may be phosphorylated by this family
of kinases. Second, the concentration range over
which the other inhibitors act supports this hypoth-
esis. Genistein, a broad range PTK inhibitor [37], has
an appreciable e¡ect at a very high concentration (50
WM). This inhibition cannot be considered speci¢c
when we recall that 5 WM are su⁄cient for complete
inhibition of phosphorylation of the EGF receptor
[37]. Instead, piceatannol has no e¡ect over the 10^
50 WM concentration range, thus excluding the in-
volvement of PTKs of the Syk family [38]. Lastly,
the inhibitory e¡ect of radicicol, although very low,
also suggests the involvement of Src family members
[39]. Based on these observations, further experi-
ments focused on verifying the presence of Src-
PTKs in mitochondria. To start with, we performed
quantitative analysis of Src kinases recovered in the
mitochondrial fraction with respect to the total cel-
lular amount. This was estimated by densitometric
scanning of Western blots of kinases on brain homo-
genate and on mitochondrial fractions obtained from
the same volume of homogenate. The presence of Src
kinase associated with the mitochondrial fraction
ranged from 4% (Lyn kinase) to 8% (Fyn kinase)
(data not shown). The ratio of Src kinase in mito-
chondria was then analysed with respect to the other
speci¢c fractions. The Western blots of Fig. 6A show
that the mitochondria contain Src-PTKs Fyn, Lyn
and Src, as well as Csk, a protein kinase which neg-
atively controls the activity of the Src family. The
activity of each enzyme (Fig. 6B) was veri¢ed by
the results of in vitro phosphorylation assays carried
out using kinases immunoprecipitated from RBM
and the exogenous substrate poly(Glu-Tyr)4:1. It is
important to point out that, in each case, measured
activity was closely related to the amounts of immu-
Fig. 2. E¡ects of oligomycin and peroxovanadate on alkali-sta-
ble protein phosphorylation of rat brain mitochondria. RBM
(50 Wg) were incubated alone at 30‡C for 10 min in the reaction
medium described in Section 2 (lane a) or in the presence of
5 WM oligomycin (lane b), 2 mM peroxovanadate (lane c) or
5 WM oligomycin plus 2 mM peroxovanadate (lane d). Samples
were analysed by 0.1% SDS^10% PAGE, and gels were trans-
ferred to PVDF membrane, immunostained with anti-HSP 60
as a protein loading standard. Then the membranes were sub-
jected to NaOH treatment as described. Lane CB, NaOH-
treated Coomassie brilliant blue-stained gel of mitochondrial
proteins. Molecular size markers are shown on the right. Auto-
radiograms were exposed for 20 h.
BBAMCR 14849 3-5-02
M. Salvi et al. / Biochimica et Biophysica Acta 1589 (2002) 181^195186
Fig. 3. Electrophoretic analysis of 32P-phosphoamino acids in acid hydrolysate of 32P-labelled rat brain mitochondria. RBM (200 Wg)
were incubated in the reaction medium as described, with 5 WM oligomycin at 30‡C for 10 min in the absence or presence of 2 mM
peroxovanadate, and then subjected to acid hydrolysis and phosphoamino acid analysis as described. Arrows in autoradiogram: ¢rst
and second directions of electrophoretic migration from origin. Panels A and B are the patterns obtained for rat brain mitochondria
incubated in the absence and presence of peroxovanadate, respectively. Autoradiograms were exposed for 24 h. This result is represen-
tative of three independent experiments.
Fig. 4. E¡ects of peroxovanadate on tyrosine kinase (A) and phosphatase (B) activities. (A) RBM (50 Wg) were incubated at 30‡C for
10 min in the reaction medium as described, with 5 WM oligomycin, in the absence (lanes a, c) or presence of 2 mM peroxovanadate
(lanes b, d). Samples were analysed by 0.1% SDS^10% PAGE, and gels were transferred to nitrocellulose membranes and immuno-
stained with anti-phosphotyrosine antibody. Lanes c and d: a previously blocked anti-phosphotyrosine antibody was used: antibody
was incubated overnight with an excess of phosphotyrosine to block all speci¢c sites. Molecular size markers are shown on the right.
(B) Tyrosine phosphatase activity in rat brain mitochondria (50 Wg), measured with poly(Glu-32P-Tyr)4:1 (0.024 WCi/1 Wg), previously
phosphorylated as described in Section 2, at 30‡C for 15 min (c), in the absence (a) or presence (b) of peroxovanadate. Samples were
analysed by 0.1% SDS^10% PAGE, and radioactivity was quanti¢ed using an Instant Imager (Packard). Tyrosine phosphatase activity
is expressed as percentage of the control value obtained in the absence of RBM. Each column represents meansR S.D. of four inde-
pendent experiments.
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Fig. 5. E¡ect of di¡erent tyrosine kinase inhibitors on the phosphorylation of a 75 kDa mitochondrial protein. RBM (50 Wg) were in-
cubated alone or in the presence of di¡erent concentrations of the indicated inhibitors for 10 min under the conditions described in
Section 2. The samples were submitted to SDS^PAGE, and gels were transferred to nitrocellulose membranes, immunostained with
anti-phosphotyrosine antibody and quanti¢ed as described in Section 2. Activity is expressed as the percentage of the control values
obtained in the absence of e¡ectors. Reported values represent means RS.D. from four separate experiments.
Fig. 6. Subcellular distribution of Lyn, Fyn, Src and Csk in rat brain. (A) Detection of Lyn, Fyn, Src and Csk in di¡ering subcellular
fractions using speci¢c antibodies. 50 Wg aliquots of mitochondria, microsomes and cytosol were subjected to SDS^PAGE, transferred
to nitrocellulose membranes, and incubated with anti-Lyn, -Fyn, -Src, and -Csk antibodies. (B) Determination of activity of Lyn,
Fyn, Src and Csk immunoprecipitated from di¡ering subcellular fractions. Protein extracts (2 mg) from mitochondria, microsomes
and cytosol were immunoprecipitated by anti-Lyn, -Fyn, -Src, or -Csk antibodies, and tyrosine kinase activity of immunocomplexes
was tested in vitro as described. Values are meansR S.D. of four independent experiments.
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nostained proteins evaluated as densitometric values.
These assays identi¢ed Fyn and Src as the most
abundant and having the highest total tyrosine ki-
nase activity found in mitochondria; Lyn and Csk
are less evident and exhibit lower activities. Compar-
isons of the ratios among the activities of these
enzymes in mitochondria, microsomes and cytosol,
taking 1 as the ratio for mitochondria, revealed dif-
ferences in distribution, as demonstrated by ratios of
1:3.85:0.19 for Fyn, 1:5.88:0.47 for Lyn, and
1:2.86:0.2 for Src. They clearly demonstrate that
the amounts of these three kinases, when evaluated
at mitochondrial level, are more abundant than in
cytoplasm and less abundant than in microsomes.
They also indicate that, when compared with other
kinases, Src is relatively more represented in mito-
chondria than in the other fractions. In fact, in these
organelles, Src exhibits the highest ratio compared
Fig. 7. Tyrosine phosphorylation in intact mitochondria in the presence of atractyloside (A) and determination of mitochondrial integ-
rity in the presence of peroxovanadate (B). (A) RBM (50 Wg) were incubated in tyrosine phosphorylation assay reaction medium as
described, with 5 WM oligomycin and 2 mM peroxovanadate in the absence or presence of 10 WM atractyloside. Samples were ana-
lysed by 0.1% SDS^10% PAGE, and gels were transferred to nitrocellulose membranes and immunostained with anti-phosphotyrosine
antibody. Molecular size markers are shown on the right. (B) RBM (50 Wg) were incubated in medium as described, with 5 mM succi-
nate, 1.25 WM rotenone and 1 mM phosphate in the absence or presence of 2 mM peroxovanadate. In (iii), the sample is supple-
mented with [14C]ADP (500 Wmol l31 ; 1.85 MBq mmol31). (i) Membrane potential, (ii) absorbance measurements and (iii) [14C]ADP
uptake.
BBAMCR 14849 3-5-02
M. Salvi et al. / Biochimica et Biophysica Acta 1589 (2002) 181^195 189
with that of cytoplasm (5 times higher) and the top
of the lower compared with that of microsomes (2.85
times lower).
We next attempted to identify the location of the
tyrosine phosphorylation detected in our assays. In-
tact RBM were incubated in standard medium sup-
plemented with oligomycin and peroxovanadate in
the absence or presence of 10 WM atractyloside, an
inhibitor of adenine nucleotide translocase. As
shown in Fig. 7, the inhibitor does not change the
phosphorylation levels of RBM proteins. Further-
more, 2 mM peroxovanadate does not alter the mi-
tochondrial membrane potential, which remains con-
stant (w160 mV), nor do their osmotic properties
change, i.e. no swelling is observed (Fig. 7, inset i
and ii, respectively). These observations demonstrate
that peroxovanadate does not a¡ect the integrity of
the membrane and that, as it does not have any e¡ect
on the translocase inhibition by atractyloside, ATP
cannot enter the matrix as a result of membrane
damage. The observed partial uptake in the presence
of the inhibitor accounts for its entry into the inner
membrane space (Fig. 7, inset iii). Therefore, the ki-
nases and their substrates appear to be located out-
side the matrix space. Subsequent experiments dealt
with identi¢cation of their speci¢c location.
To study subcompartmentalization of substrates,
after tyrosine phosphorylation, mitochondria were
subfractionated and membranes separated from solu-
ble fractions (see Section 2). The results (Fig. 8) show
that all three proteins are located in the membrane
fraction (lane M), and that they do not appear in the
soluble fraction (lane S). These observations high-
light the involvement of the outer membrane and/
or external surface of the inner membrane as the
location of PTK substrates.
For further information on PTK location, enolase
was used as an exogenous substrate (45 kDa) which
cannot cross the outer membrane (permeable to mol-
ecules lower than 10 kDa). The results (Fig. 9) dem-
onstrate that enolase is much less phosphorylated by
a suspension of intact mitochondria than by one of
mitochondria previously broken, as described in Sec-
tion 2. This experiment clearly shows that PTKs are
mainly located between the outer and inner mem-
branes of mitochondria, and are not exposed on
the external surface.
To identify a more detailed location, intact mito-
chondria were subjected to digitonin treatment. Dig-
itonin interacts with cholesterol, forming a complex
in a 1:1 ratio, resulting in slight molecular disorder-
ing of the membrane at low concentrations. Increas-
ing amounts of digitonin have the characteristic se-
lective e¡ect of disrupting the membrane, revealed in
release of marker enzymes from brain mitochondria
[27]. This di¡erential release takes place from the
intermembrane space/outer membrane compartment,
because the inner membrane is lacking in cholesterol.
The results (Fig. 10) show the e¡ects of a low
concentration of digitonin (0.2 mg/mg mitochondrial
protein). After treatment, mitochondria were sepa-
rated from the supernatant and tyrosine kinase ac-
tivity was assayed in both fractions by means of
exogenous substrate enolase (see Section 2). As
shown (Fig. 10, lane a), the supernatant fraction ex-
hibits clear-cut phosphorylation activity, but the mi-
tochondrial fraction does not (lane b). As the exter-
Fig. 8. Endogenous tyrosine-phosphorylated proteins. RBM (50
Wg) were incubated in tyrosine phosphorylation assay reaction
medium as described, with 5 WM oligomycin and 2 mM peroxo-
vanadate. RBM were then broken (T) and mitochondrial mem-
branes (M) were separated from the soluble fraction (S) as de-
scribed. Samples were analysed by 0.1% SDS^10% PAGE, and
gels were transferred to nitrocellulose membranes and immuno-
stained with anti-phosphotyrosine antibody. Molecular size
markers are shown on the right (bottom). Coomassie stained
gel of broken mitochondria: mitochondrial membranes and
soluble fraction (top).
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nal surface of mitochondria, demonstrated in the ex-
periment with intact mitochondria (Fig. 9), does not
exert any tyrosine kinase activity, the observed activ-
ity in the supernatant cannot be due to release of
PTKs from the external surface of the outer mem-
brane, but is almost certainly due to migration from
the intermembrane space. This conclusion is strongly
supported by the observation that enzyme release
into the supernatant after digitonin treatment is ac-
companied by release of the intermembrane marker
adenylate kinase, but not by that of the outer mem-
brane marker monoamine oxidase, which is detected
in the mitochondrial fraction (Fig. 10B). This result
is most probably due to some leak pathway which
induces e¥ux from the intermembrane space of solu-
ble enzymes without disrupting or greatly damaging
the outer membrane, as previously demonstrated
[27]. The same results on phosphorylation activity,
which con¢rm the location of PTKs in the intermem-
brane space, were achieved with a high concentration
of digitonin (0.6 mg/mg mitochondrial protein) (see
Fig. 10A). It should be stressed that, in this condi-
tion, besides adenylate kinase, monoamine oxidase is
also detected in the supernatant fraction, thus ex-
plaining outer membrane disruption (Fig. 10B).
The integrity of the inner membrane after treat-
ment with high digitonin concentrations is demon-
strated by the detection of cytochrome c oxidase (in-
ner membrane) and malate dehydrogenase activity
(matrix) only in the fractions of mitoplasts (mito-
chondria deprived of their outer membrane by con-
centrated digitonin treatment) (Fig. 10B) and by the
high v8 value exhibited by these organelles (result
not reported). This fact also demonstrates that the
Fig. 9. Tyrosine phosphorylation of exogenous substrate (enolase) by intact and broken mitochondria. Intact (I) and broken (B) RBM
(50 Wg) were incubated in tyrosine phosphorylation assay reaction medium as described, with 5 WM oligomycin and 2 mM peroxova-
nadate plus enolase. Samples were analysed by 0.1% SDS^10% PAGE, and gels were subjected to NaOH treatment as described.
Fig. 10. Tyrosine kinase activity by di¡erent fractions of digitonin-treated mitochondria. Mitochondria were fractionated by the digito-
nin method as described. (A) The resulting two fractions (soluble and pellet) were incubated in tyrosine phosphorylation assay reac-
tion medium as described, with 5 WM oligomycin and 2 mM peroxovanadate plus enolase. Samples were analysed by 0.1% SDS^10%
PAGE, and gels were subjected to NaOH treatment as described. (B) Marker enzyme assay on supernatants after digitonin treatment.
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PTKs identi¢ed in the supernatant are not of inner
membrane origin.
To con¢rm these biochemical results, we used an
ultramicroscopic technique for direct visual localiza-
tion of Lyn kinase in mitochondria. RBM treated
with antibodies gold labelled against Lyn kinase
were labelled with 5^15 gold particles (Fig. 11A).
All the particles were found in the intermembrane
space. In this regard, this space can be functionally
separated into two subcompartments: the cristal lu-
men, and the intermembrane space lying between the
inner and outer membranes [13]. As shown even
more clearly in Fig. 11B, all the labelled gold appears
in both subcompartments, but mainly in the cristal
lumen. In contrast, no labelling was found in the
matrix. In the absence of the Lyn kinase antibody,
no mitochondria showed labelling (Fig. 11C).
4. Discussion
The patterns of endogenously phosphorylated mi-
tochondrial proteins detected in isolated mitochon-
dria are very intriguing. Three major phosphopro-
teins of 50, 60, 75 kDa as well as others of various
sizes were detected (see Fig. 2). The requirement of
Mn2þ, an essential cofactor for in vitro tyrosine ki-
nase activity, the stimulatory e¡ects of peroxovana-
date, a well-known inhibitor of tyrosine phosphatase
activity [35], and the stability of phosphorylation to
alkaline hydrolysis, all clearly demonstrate that
RBM contains tyrosine kinase and that it has several
endogenous substrates. Maximum phosphotyrosine
labelling occurs in the presence of oligomycin, an
inhibitor of F1F0-ATPase, which protects ATP
from hydrolysis. The addition of peroxovanadate
produces a substantial increase in phosphorylation
on Tyr but does not a¡ect that on Ser and Thr
(Fig. 3B). The anti-phosphotyrosine antibody con-
¢rms that all three proteins, 50, 60 and 75 kDa,
are phosphorylated on tyrosine residues. The neces-
sary presence of peroxovanadate for tyrosine phos-
phorylation correlated with the inhibition of tyrosine
phosphatase activity in rat brain mitochondria (Fig.
4B) clearly shows that the level of tyrosine phosphor-
ylation re£ects not only the activity of tyrosine ki-
nases but also protein tyrosine phosphatase in coor-
dination.
The ability of PP2 to alter peroxovanadate-depen-
dent phosphorylation patterns had provided a good
indication of the types of tyrosine kinases present in
RBM, as PP2 is a highly potent inhibitor of non-
receptor tyrosine kinases ^ mainly of tyrosine kinase
belonging to the Src family [36]. Its e¡ects, and those
Fig. 11. Immunogold detection of Lyn kinase in RBM. (A,B) Immunogold labelling of Lyn kinase (arrows) of isolated RBM. (A)
Magni¢cation, U20 000. (B) Magni¢cation, U68 000. (C) As negative control, gold-labelled secondary antibody was applied in the ab-
sence of Lyn antibody; no Lyn protein was detected.
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of genistein, piceatannol and radicicol, other well-
known inhibitors of tyrosine phosphorylation (see
Fig. 5), had been a good indication that members
of the Src family can phosphorylate individual phos-
phoproteins.
The results (Fig. 6) show that several members of
this family (Src, Fyn, Lyn) accompanied by the Src-
PTK activity regulator, Csk, are found in RBM, Fyn
and Src being the most abundant and active. It is
also noteworthy that, compared with other kinases,
Src exhibits the highest ratio between mitochondria
and microsomes. The activity of Src-PTKs in cells of
di¡ering types is negatively controlled through phos-
phorylation of their C-terminal tyrosine residues by
Csk, which is mainly cytoplasmic, whereas Src-PTKs
are predominantly plasma membrane-associated. The
presence of Src-PTKs and their substrates, accompa-
nied by Csk in brain mitochondria, indicates that
these organelles give rise to regulated tyrosine phos-
phorylation/dephosphorylation closely associated
with their functions. As discussed above, this hypoth-
esis is strongly supported by the identi¢cation of ty-
rosine phosphatase activity (Fig. 4B).
Many e¡orts have been made to establish the exact
location of tyrosine kinases and their substrates. The
results reported here clearly show that the 50, 60 and
75 kDa proteins, substrates of mitochondrial PTKs,
are membrane-bound (Fig. 8), particularly on the
inner surface of the outer membrane and/or the outer
surface of the inner membrane. Although the identity
of these proteins cannot yet be established precisely,
a 75 kDa protein has been identi¢ed, belonging to
the heat shock family, present in the mitochondrial
fraction of rat hepatoma cells, which undergoes a
marked increase in tyrosine phosphorylation level
[40]. Tyrosine phosphorylation of this protein is se-
lective, as other members of this family do not ex-
hibit phosphorylation. The 60 kDa protein Grb 10,
belonging to a small family of adapter proteins and
found in several tumours and cell lines, has been
recognized as a mitochondrial protein, most prob-
ably located in the outer membrane [41]. Grb 10
has also been identi¢ed as a direct substrate for
Src-PTK members [42] and may play a role in signal-
ling regulation between plasma membrane receptors
and the apoptosis-inducing machinery located on the
mitochondrial outer membrane [41]. Experiments are
in progress to verify whether the above-mentioned 75
kDa heat shock and Grb 10 proteins are also present
in brain mitochondria. Moreover, a Src kinase-de-
pendent channel, closely involved in the regulation
of apoptosis is present in the plasma membrane
[43], a similar channel has very recently been identi-
¢ed in the inner mitochondrial membrane (I. Szabo',
pers. commun.).
Src-PTKs are generally extrinsic proteins, bound
to plasma and intracellular membranes by hydropho-
bic interactions occurring between their myristoy-
lated and/or palmitoylated tails and membrane pro-
teins having selective a⁄nity for acylated proteins
[44]. The results reported in this paper show that
most activity occurs in the intermembrane space
and less in the mitoplast fraction, meaning that a
few kinases are also inner membrane-bound. As
mentioned above, acylation of these proteins is nec-
essary for their membrane insertion [3,4], but some
myristoylated Src molecules have also been found
free in the cytosol [45], indicating that myristoylation
does not guarantee membrane association. Indeed,
non-myristoylated Src molecules are also found in
the soluble fraction [46]. Although the results re-
ported here do not allow us to state whether the
Src-PTKs identi¢ed in the intermembrane space are
acylated or not, a very important point must be em-
phasized. Some reviews have reported that Src-PTKs
need to remain at the membrane in order to signal
and that their detachment from it means loss of ac-
tivity and of speci¢c location. It is recognized that
non-myristoylated and soluble myristoylated proteins
still retain their speci¢c properties [46] and the abro-
gation of myristoylation may lead to a highly speci¢c
alternative pattern of location [45]. The immunogold
experiment (results shown in Fig. 11) clearly demon-
strates the presence of Lyn kinase in brain mitochon-
dria. In particular, its location appears to be associ-
ated with cristal structures. However, taking into
account the results reported above, demonstrating
that most Src kinases are present in the intermem-
brane space, Lyn kinase should also be present in the
cristal lumen.
Src-PTKs regulate a plethora of events, including
cell growth, division, di¡erentiation, survival, and
death of eukaryotic cells, and are particularly impor-
tant in controlling communications between and
within cells through signal transduction pathways
[5^8]. Several members of the Src family, including
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Src, Fyn, Lyn and Yes, are known to be highly ex-
pressed in the central nervous system and play im-
portant roles in both its development and function
[47]. The possibility that, besides the recognized en-
dogenous substrates, other exogenous peptides or
proteins able to cross the inner membrane can be
phosphorylated by Src-PTKs, allows speculation on
the role played by these enzymes. A very recent pa-
per reports that genistein, a speci¢c natural tyrosine
kinase inhibitor [37], can induce apoptosis of RPE-J
cells [48], perhaps due to opening of the mitochon-
drial permeability transition pore which promotes
cytochrome c release, a phenomenon closely con-
nected with apoptosis [11^13]. Results obtained in
our laboratory have also shown that genistein can
induce permeability transition in isolated brain mito-
chondria, whereas peroxovanadate is a strong inhib-
itor of the phenomenon (manuscript in preparation).
These observations, which must be con¢rmed using
other speci¢c inhibitors of tyrosine kinases and phos-
phatases, ¢t the hypothesis that tyrosine phosphory-
lation/dephosphorylation is involved in the modula-
tion of neuronal pro-apoptotic signal transduction.
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